INTEGRAL HEALTH ASSET MANAGEMENT, LLC
Adviser information for INTEGRAL HEALTH ASSET MANAGEMENT, LLC last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 10 |
---|---|
Investment Advisory/Research | 7 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 12 | $815.2M |
Non-Discretionary | 0 | $0 |
Total | 12 | $815.2M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 12 | $815.2M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 74 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
437 MADISON AVE., 19TH FLOORNEW YORK
NY
United States
Monday - Friday, 8:00 AM - 5:00PM
Tel: 201-370-2740, Fax: None
Websites
Chief Compliance Officer
JOHN DEL VIRGINIA
CHIEF OPERATING OFFICER
437 MADISON AVE., 19TH FLOOR
NEW YORK
NY
United States
Tel:
201-370-2740
J**@***************M
(Full email address available in API data)
Industry Affiliates
INTEGRAL HEALTH GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
INTEGRAL HEALTH NEWTON MASTER FUND, LP | Hedge Fund | $51.7M | $1.0M | 12 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
Rao, Bhagwan Jay | Individual | – | CHIEF INVESTMENT OFFICER | 02/2019 | < 5% |
DEL VIRGINIA, JOHN | Individual | – | CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER | 09/2021 | < 5% |
INTEGRAL HEALTH ADVISORS, LP | Domestic Entity | – | LIMITED PARTNER | 09/2022 | > 75% |
Rao, Bhagwan Jay | Individual | INTEGRAL HEALTH ADVISORS, LP | MANAGING MEMBER | 09/2022 | > 75% |
DEL VIRGINIA, JOHN | Individual | INTEGRAL HEALTH ADVISORS, LP | CHIEF OPERATING OFFICER/CHIEF COMPLIANCE OFFICER | 09/2022 | |
INTEGRAL HEALTH ADVISORS GP, LLC | Domestic Entity | INTEGRAL HEALTH ADVISORS, LP | GENERAL PARTNER | 09/2022 | |
CHOU, TIMOTHY, W | Individual | INTEGRAL HEALTH ADVISORS, LP | SENIOR ANALYST | 09/2022 | |
Rao, Bhagwan Jay | Individual | INTEGRAL HEALTH ADVISORS GP, LLC | MANAGING MEMBER | 09/2022 | 50-75% |
Fishman, Cybele | Individual | INTEGRAL HEALTH ADVISORS GP, LLC | MEMBER | 09/2022 | 50-75% |
Virgilio, Alex, Adam | Individual | INTEGRAL HEALTH ADVISORS, LP | SENIOR ANALYST | 04/2023 |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
89BIO INC | COM | 4M | 450K | – |
AMGEN INC | COM | 12M | 40K | – |
APOGEE THERAPEUTICS INC | COM | 3M | 80K | – |
ARCELLX INC | COMMON STOCK | 15M | 275K | – |
BECTON DICKINSON & CO | COM | 18M | 75K | – |
BLUEPRINT MEDICINES CORP | COM | 37M | 340K | – |
BOSTON SCIENTIFIC CORP | COM | 50M | 650K | – |
BRUKER CORP | COM | 8M | 130K | – |
CABALETTA BIO INC | COM | 3M | 425K | – |
CATALYST PHARMACEUTICALS INC | COM | 4M | 275K | – |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 5M | 100K | – |
CRINETICS PHARMACEUTICALS IN | COM | 18M | 400K | – |
CRISPR THERAPEUTICS AG | NAMEN AKT | 8M | 150K | – |
CYTOKINETICS INC | COM NEW | 54M | 1M | – |
DENALI THERAPEUTICS INC | COM | 8M | 325K | – |
DYNE THERAPEUTICS INC | COM | 4M | 100K | – |
EDITAS MEDICINE INC | COM | 3M | 675K | – |
EDWARDS LIFESCIENCES CORP | COM | 14M | 150K | – |
ELANCO ANIMAL HEALTH INC | COM | 6M | 450K | – |
ELEVANCE HEALTH INC | COM | 43M | 80K | – |
ELI LILLY & CO | COM | 9M | 10K | – |
ENCOMPASS HEALTH CORP | COM | 26M | 300K | – |
FATE THERAPEUTICS INC | COM | 3M | 850K | – |
GLOBUS MED INC | CL A | 9M | 125K | – |
HOLOGIC INC | COM | 4M | 50K | – |
HUMANA INC | COM | 28M | 75K | – |
ICON PLC | SHS | 14M | 45K | – |
INARI MED INC | COM | 19M | 400K | – |
INSMED INC | COM PAR $.01 | 104M | 2M | – |
INSULET CORP | COM | 5M | 25K | – |
INTRA-CELLULAR THERAPIES INC | COM | 10M | 145K | – |
INTUITIVE SURGICAL INC | COM NEW | 4M | 10K | – |
IONIS PHARMACEUTICALS INC | COM | 12M | 250K | – |
IONIS PHARMACEUTICALS INC | COM | 24M | 500K | – |
KEROS THERAPEUTICS INC | COM | 4M | 85K | – |
KRYSTAL BIOTECH INC | COM | 16M | 85K | – |
KURA ONCOLOGY INC | COM | 2M | 100K | – |
LONGBOARD PHARMACEUTICALS IN | COM | 30M | 1M | – |
MCKESSON CORP | COM | 12M | 20K | – |
MERCK & CO INC | COM | 29M | 235K | – |
MEREO BIOPHARMA GROUP PLC | SPON ADS | 6M | 2M | – |
MERUS N V | COM | 6M | 100K | – |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 10M | 220K | – |
NEUROCRINE BIOSCIENCES INC | COM | 10M | 70K | – |
NEUROGENE INC | COM | 3M | 70K | – |
NOVARTIS AG | SPONSORED ADR | 32M | 300K | – |
NURIX THERAPEUTICS INC | COM | 3M | 150K | – |
OSCAR HEALTH INC | CL A | 8M | 500K | – |
QUEST DIAGNOSTICS INC | COM | 14M | 100K | – |
QUIDELORTHO CORP | COM | 5M | 150K | – |
REGENXBIO INC | COM | 11M | 950K | – |
RELAY THERAPEUTICS INC | COM | 5M | 750K | – |
REPLIGEN CORP | COM | 8M | 60K | – |
REVANCE THERAPEUTICS INC | COM | 1M | 500K | – |
REVOLUTION MEDICINES INC | COM | 13M | 325K | – |
ROIVANT SCIENCES LTD | SHS | 4M | 400K | – |
SANA BIOTECHNOLOGY INC | COM | 7M | 1M | – |
SANOFI | SPONSORED ADR | 10M | 200K | – |
SCHOLAR ROCK HLDG CORP | COM | 3M | 400K | – |
SPYRE THERAPEUTICS INC | COM NEW | 2M | 100K | – |
SURGERY PARTNERS INC | COM | 5M | 200K | – |
TARSUS PHARMACEUTICALS INC | COM | 16M | 590K | – |
TARSUS PHARMACEUTICALS INC | COM | 11M | 400K | – |
TELEFLEX INCORPORATED | COM | 9M | 45K | – |
TENAYA THERAPEUTICS INC | COM | 7M | 2M | – |
TENET HEALTHCARE CORP | COM NEW | 67M | 500K | – |
THE CIGNA GROUP | COM | 17M | 50K | – |
THERMO FISHER SCIENTIFIC INC | COM | 14M | 25K | – |
UNIVERSAL HLTH SVCS INC | CL B | 24M | 130K | – |
VERA THERAPEUTICS INC | CL A | 18M | 500K | – |
VIKING THERAPEUTICS INC | COM | 13M | 250K | – |
VIKING THERAPEUTICS INC | COM | 13M | 250K | – |